"ovarian borderline tumor histologic" trang 13 - tải miễn phí từ tailieunhanh
Chemotherapy-induced hyaluronan production: A novel chemoresistance mechanism in ovarian cancer

Chemotherapy-induced hyaluronan production: A novel chemoresistance mechanism in ovarian cancer
12    25    1
MiR-200c and HuR in ovarian cancer

MiR-200c and HuR in ovarian cancer
14    61    1
Use of ß-blockers and mortality following ovarian cancer diagnosis: A population-based cohort study

Use of ß-blockers and mortality following ovarian cancer diagnosis: A population-based cohort study
7    24    1
Sugary food and beverage consumption and epithelial ovarian cancer risk: A population-based case–control study

Sugary food and beverage consumption and epithelial ovarian cancer risk: A population-based case–control study
12    58    1
The prognostic value of estrogen receptor beta and proline glutamic acid- and leucine-rich protein 1 (PELP1) expression in ovarian cancer

The prognostic value of estrogen receptor beta and proline glutamic acid- and leucine-rich protein 1 (PELP1) expression in ovarian cancer
7    57    1
A combined blood based gene expression and plasma protein abundance signature for diagnosis of epithelial ovarian cancer - a study of the OVCAD consortium

A combined blood based gene expression and plasma protein abundance signature for diagnosis of epithelial ovarian cancer - a study of the OVCAD consortium
13    62    1
Steroid hormone receptor expression in ovarian cancer: Progesterone receptor B as prognostic marker for patient survival

Steroid hormone receptor expression in ovarian cancer: Progesterone receptor B as prognostic marker for patient survival
9    36    1
Autophagy-independent enhancing effects of Beclin 1 on cytotoxicity of ovarian cancer cells mediated by proteasome inhibitors

Autophagy-independent enhancing effects of Beclin 1 on cytotoxicity of ovarian cancer cells mediated by proteasome inhibitors
11    55    1
Establishment and verification of the nomogram that predicts the 3-year recurrence risk of epithelial ovarian carcinoma

Establishment and verification of the nomogram that predicts the 3-year recurrence risk of epithelial ovarian carcinoma
9    36    1
A network model for angiogenesis in ovarian cancer

A network model for angiogenesis in ovarian cancer
17    31    1
R-spondins are involved in the ovarian differentiation in a teleost, medaka (Oryzias latipes)

R-spondins are involved in the ovarian differentiation in a teleost, medaka (Oryzias latipes)
11    34    1
MicroRNA-545 suppresses progression of ovarian cancer through mediating PLK1 expression by a direct binding and an indirect regulation involving KDM4Bmediated demethylation

MicroRNA-545 suppresses progression of ovarian cancer through mediating PLK1 expression by a direct binding and an indirect regulation involving KDM4Bmediated demethylation
16    32    1
Factors determining ultra-short-term survival and the commencement of active treatment in high-grade serous ovarian cancer: A case comparison study

Factors determining ultra-short-term survival and the commencement of active treatment in high-grade serous ovarian cancer: A case comparison study
9    38    1
Reprogramming of glutamine metabolism via glutamine synthetase silencing induces cisplatin resistance in A2780 ovarian cancer cells

Reprogramming of glutamine metabolism via glutamine synthetase silencing induces cisplatin resistance in A2780 ovarian cancer cells
11    46    1
The R-enantiomer of ketorolac reduces ovarian cancer tumor burden in vivo

The R-enantiomer of ketorolac reduces ovarian cancer tumor burden in vivo
16    40    1
Mucinous, endometrioid, and serous ovarian cancers with peritoneal dissemination are potent candidates for Pcadherin targeted therapy: A retrospective cohort study

Mucinous, endometrioid, and serous ovarian cancers with peritoneal dissemination are potent candidates for Pcadherin targeted therapy: A retrospective cohort study
9    46    1
Patients with low nicotinamide Nmethyltransferase expression benefit significantly from bevacizumab treatment in ovarian cancer

Patients with low nicotinamide Nmethyltransferase expression benefit significantly from bevacizumab treatment in ovarian cancer
10    49    1
Survival impact of extended cycles of second-line chemotherapy in platinum-sensitive relapsed ovarian cancer patients with residual tumor after six cycles

Survival impact of extended cycles of second-line chemotherapy in platinum-sensitive relapsed ovarian cancer patients with residual tumor after six cycles
11    22    1
Bioinformatics analysis of mRNA and miRNA microarray to identify the key miRNA-mRNA pairs in cisplatin-resistant ovarian cancer

Bioinformatics analysis of mRNA and miRNA microarray to identify the key miRNA-mRNA pairs in cisplatin-resistant ovarian cancer
13    29    1
Incidence and survival of epithelial ovarian, fallopian tube, peritoneal, and undesignated abdominal/pelvic cancers in Sweden 1960–2014: A population-based cohort study

Incidence and survival of epithelial ovarian, fallopian tube, peritoneal, and undesignated abdominal/pelvic cancers in Sweden 1960–2014: A population-based cohort study
13    29    1